Status:
COMPLETED
Lypo-hypertrofia Characterization in Diabetes
Lead Sponsor:
Niguarda Hospital
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Brief Summary
Aim/hypothesis: Subcutaneous insulin absorption is one of the factors which strongly influence blood sugar control in patients with diabetes mellitus on insulin therapy. In response, a regular absorpt...
Detailed Description
An observational study has been carried out, checked with parallel arms in which type 1 diabetes patients are recruited with clinical evidence of lypo-hypertrophy in insulin injected areas. Patients a...
Eligibility Criteria
Inclusion
- type 1 diabetes
- age between 18 and 75 years old
- lack of extended cutaneous diseases
- BMI \<30
Exclusion
- BMI\> 30
- active allergies
- cancer
- liver failure
- kidney failure
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02278926
Start Date
January 1 2012
End Date
October 1 2014
Last Update
November 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nigurada Hospital
Milan, Italy, 20162